Corcept Therapeutics (CORT) Stock Highlights

56.09 | +3.28%

2024-11-21 01:28:23

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

Statistics

Range Today

54.02 56.13

Volume Today 933.12K

Range 1 Year

20.84 61.66

Volume 1 Year 283.37M

Range 3 Year

15.83 61.66

Volume 3 Year 722.36M

Range 10 Year

2.69 61.66

Volume 10 Year 2.33B

Highlights

Market Capitalization 6.24B (mid)

Floating Shares 85.66M

Current Price 56.09

Price To Earnings 39.35

Price To Revenue 8.46

Price To Book 9.77

Earnings Per Share 1.38

Payout Ratio 0%

Performance

Latest +3.28%

1 Month +12.36%

3 Months +62.25%

6 Months +100.25%

1 Year +116.73%

3 Years +145.26%

5 Years +231.89%

10 Years +1794.93%

Benchmarks

Market Capitalization

69 / 368

Gross Profits

19 / 278

Total Revenue

25 / 300

Total Rank

92 / 368

Free Cashflow

11 / 352

Performance 5 years

38 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.